Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study.

Rimola A, Salmerón JM, Clemente G, Rodrigo L, Obrador A, Miranda ML, Guarner C, Planas R, Solá R, Vargas V, et al.

Hepatology. 1995 Mar;21(3):674-9.

PMID:
7875666
2.

Experience with cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis.

Rimola A, Navasa M, Arroyo V.

Diagn Microbiol Infect Dis. 1995 May-Jun;22(1-2):141-5. Review.

PMID:
7587029
3.

Aztreonam vs. cefotaxime in the treatment of gram-negative spontaneous peritonitis in cirrhotic patients.

Ariza J, Xiol X, Esteve M, Fernández Bañeres F, Liñares J, Alonso T, Gudiol F.

Hepatology. 1991 Jul;14(1):91-8.

PMID:
2066075
4.

Spontaneous ascitic infection in different cirrhotic groups: prevalence, risk factors and the efficacy of cefotaxime therapy.

Kaymakoglu S, Eraksoy H, Okten A, Demir K, Calangu S, Cakaloglu Y, Boztas G, Besisik F.

Eur J Gastroenterol Hepatol. 1997 Jan;9(1):71-6.

PMID:
9031903
5.

Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients.

Ricart E, Soriano G, Novella MT, Ortiz J, Sàbat M, Kolle L, Sola-Vera J, Miñana J, Dedéu JM, Gómez C, Barrio JL, Guarner C.

J Hepatol. 2000 Apr;32(4):596-602.

PMID:
10782908
6.

Oral ciprofloxacin versus intravenous cefotaxime and ceftriaxone in the treatment of spontaneous bacterial peritonitis.

Tuncer I, Topcu N, Durmus A, Turkdogan MK.

Hepatogastroenterology. 2003 Sep-Oct;50(53):1426-30.

PMID:
14571754
7.

Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients.

Runyon BA, McHutchison JG, Antillon MR, Akriviadis EA, Montano AA.

Gastroenterology. 1991 Jun;100(6):1737-42.

PMID:
2019378
8.

Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime.

Toledo C, Salmerón JM, Rimola A, Navasa M, Arroyo V, Llach J, Ginès A, Ginès P, Rodés J.

Hepatology. 1993 Feb;17(2):251-7.

PMID:
8428722
9.

Comparison of cefotaxime and ofloxacin in treatment of spontaneous bacterial peritonitis.

Taşkiran B, Colakoğlu O, Sözmen B, Unsal B, Aslan SL, Buyraç Z.

Turk J Gastroenterol. 2004 Mar;15(1):34-8.

10.

Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis.

Navasa M, Follo A, Llovet JM, Clemente G, Vargas V, Rimola A, Marco F, Guarner C, Forné M, Planas R, Bañares R, Castells L, Jimenez De Anta MT, Arroyo V, Rodés J.

Gastroenterology. 1996 Oct;111(4):1011-7.

PMID:
8831596
11.

Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites.

Sandhu BS, Gupta R, Sharma J, Singh J, Murthy NS, Sarin SK.

J Gastroenterol Hepatol. 2005 Apr;20(4):599-605.

PMID:
15836710
12.

[Bacterial peritonitis in cirrhosis. Prospective study of 80 episodes].

Gómez-Jiménez J, Ribera E, Martínez-Vázquez JM, Gasser I, Segura RM.

Med Clin (Barc). 1992 Oct 24;99(13):493-7. Spanish.

PMID:
1434973
13.

The value of ascitic fluid polymorphonuclear cell count determination during therapy of spontaneous bacterial peritonitis in patients with liver cirrhosis.

Ljubicic N, Spajic D, Vrkljan MM, Altabas V, Doko M, Zovak M, Gacina P, Mihatov S.

Hepatogastroenterology. 2000 Sep-Oct;47(35):1360-3.

PMID:
11100352
14.

Spontaneous bacterial peritonitis and culture negative neutrocytic ascites in patients with non-alcoholic liver cirrhosis.

al Amri SM, Allam AR, al Mofleh IA.

J Gastroenterol Hepatol. 1994 Sep-Oct;9(5):433-6.

PMID:
7827291
15.

Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.

Novella M, Solà R, Soriano G, Andreu M, Gana J, Ortiz J, Coll S, Sàbat M, Vila MC, Guarner C, Vilardell F.

Hepatology. 1997 Mar;25(3):532-6.

PMID:
9049193
16.

Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.

Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, Castells L, Vargas V, Soriano G, Guevara M, Ginès P, Rodés J.

N Engl J Med. 1999 Aug 5;341(6):403-9.

17.

Clinical and laboratory features of spontaneous bacterial peritonitis.

Filik L, Unal S.

East Afr Med J. 2004 Sep;81(9):474-9.

PMID:
15626058
18.

Prevalence and prognostic significance of bacterascites in cirrhosis with ascites.

Chu CM, Chang KY, Liaw YF.

Dig Dis Sci. 1995 Mar;40(3):561-5.

PMID:
7895544
19.

Spontaneous bacterial peritonitis (SBP) in cirrhotic ascites: a prospective study in a tertiary care hospital, Nepal.

Syed VA, Ansari JA, Karki P, Regmi M, Khanal B.

Kathmandu Univ Med J (KUMJ). 2007 Jan-Mar;5(1):48-59.

PMID:
18603986
20.

[Spontaneous bacterial peritonitis: diagnostic and prognostic aspects].

Henz S, Bühler H, Pirovino M.

Schweiz Med Wochenschr. 1995 Dec 9;125(49):2379-86. German.

PMID:
8848698

Supplemental Content

Support Center